Intelligent Investor

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.470 0.01 (0.40%)

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$578 Change of Director's Interest Notice - Toby Hall 4 Apr 2024 8:56AM $2.430 $2.470 $2.370 risen by 1.65%
$578 Application for quotation of securities - IDX 4 Apr 2024 8:49AM $2.430 $2.470 $2.370 risen by 1.65%
$578 Update - Dividend/Distribution - IDX 18 Mar 2024 6:12PM $2.150 $2.470 $2.370 risen by 14.88%
$578 Ceasing to be a substantial holder 22 Feb 2024 2:35PM $2.165 $2.470 $2.370 risen by 14.09%
$578 Notification of cessation of securities - IDX 20 Feb 2024 6:43PM $2.240 $2.470 $2.370 risen by 10.27%
$578 Update - Dividend/Distribution - IDX 20 Feb 2024 6:41PM $2.240 $2.470 $2.370 risen by 10.27%
$578 Half Year Results Investor Presentation 20 Feb 2024 8:07AM $2.090 $2.470 $2.370 risen by 18.18%
$578 Half Year Results Media Release 20 Feb 2024 8:07AM $2.090 $2.470 $2.370 risen by 18.18%
$578 Dividend/Distribution - IDX 20 Feb 2024 8:07AM $2.090 $2.470 $2.370 risen by 18.18%
$578 Half Yearly Report and Accounts 20 Feb 2024 8:06AM $2.090 $2.470 $2.370 risen by 18.18%
$578 Becoming a substantial holder 19 Feb 2024 4:06PM $2.110 $2.470 $2.370 risen by 17.06%
$578 FY24 IDX Half Year Results Release Date and Conference Call 18 Jan 2024 9:43AM $1.890 $2.470 $2.370 risen by 30.69%
$578 Ceasing to be a substantial holder from MQG 5 Jan 2024 5:24PM $1.885 $2.470 $2.370 risen by 31.03%
$578 Becoming a substantial holder from MQG 29 Dec 2023 3:10PM $1.900 $2.470 $2.370 risen by 30%
$578 Change in substantial holding 18 Dec 2023 4:11PM $1.910 $2.470 $2.370 risen by 29.32%
$578 Change of Company Secretary 12 Dec 2023 8:52AM $1.865 $2.470 $2.370 risen by 32.44%
$578 Ceasing to be a substantial holder 7 Dec 2023 7:22PM $1.860 $2.470 $2.370 risen by 32.80%
$578 Becoming a substantial holder 5 Dec 2023 8:28PM $1.755 $2.470 $2.370 risen by 40.74%
$578 Change of Director's Interest Notice - Ian Kadish 5 Dec 2023 10:46AM $1.780 $2.470 $2.370 risen by 38.76%
$578 Change of Director's Interest Notice - Andrew Fay 4 Dec 2023 11:40AM $1.710 $2.470 $2.370 risen by 44.44%
$578 Change of Director's Interest Notice - Toby Hall 4 Dec 2023 10:57AM $1.710 $2.470 $2.370 risen by 44.44%
$578 Change of Director's Interest Notice - Ingrid Player 4 Dec 2023 10:51AM $1.710 $2.470 $2.370 risen by 44.44%
$578 Change of Director's Interest Notice - Ian Kadish 1 Dec 2023 9:23AM $1.775 $2.470 $2.370 risen by 39.15%
$578 Notification regarding unquoted securities - IDX 30 Nov 2023 3:20PM $1.755 $2.470 $2.370 risen by 40.74%
$578 Final Director's Interest Notice - Helen Kurincic 30 Nov 2023 11:13AM $1.720 $2.470 $2.370 risen by 43.60%

1 - 25 of 579 results

Page 1 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.